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Injury to the peripheral axons of sensory neurons strongly enhances the regeneration of their 
central axons in the spinal cord. It remains unclear on what molecules that initiate such 
conditioning effect. Since ATP is released extracellularly by nerve and other tissue injury, we 
hypothesize that injection of ATP into a peripheral nerve might mimic the stimulatory effect 
of nerve injury on the regenerative state of the primary sensory neurons. We found that a 
single injection of 6 µl of 150 M ATP into female rat sciatic nerve quadrupled the number 
of axons growing into a lesion epicenter in spinal cord after a concomitant dorsal column 
transection. A second boost ATP injection one week after the first one markedly reinforced 
the stimulatory effect of a single injection. Single ATP injection increased expression of 
phospho-STAT3 and GAP43, two markers of regenerative activity, in sensory neurons. 
Double ATP injections sustained the activation of phospho-STAT3 and GAP43, which may 
account for the marked axonal growth across the lesion epicenter. Similar studies carried out 
on P2X7 or P2Y2 receptor knockout mice indicate P2Y2 receptors are involved in the 
activation of STAT3 after ATP injection or conditioning lesion, while P2X7 receptors are 
not. Injection of ATP at 150 M caused little Wallerian degeneration and behavioral tests 
showed no significant long-term adverse effects on sciatic nerve functions. The results in this 
study reveal possible mechanisms underlying the stimulation of regenerative programs and 
suggest a practical strategy for stimulating axonal regeneration following spinal cord injury.  
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Significance Statement  
Injury of peripheral axons of sensory neurons has been known to strongly enhance the 
regeneration of their central axons in the spinal cord. In this study, we found that injection of 
ATP into a peripheral nerve can mimic the effect of peripheral nerve injury and significantly 
increase the number of sensory axons growing across lesion epicenter in the spinal cord. ATP 
injection increased expression of several markers for regenerative activity in sensory neurons, 
including phospho-STAT3 and GAP43. ATP injection did not cause significant long-term 
adverse effects on the functions of the injected nerve. These results may lead to clinically 





Weak intrinsic regenerative capacity of injured neurons in the adult mammalian central 
nervous system (CNS) is a major obstacle for neural repair. Efficacious approaches to elevate 
the regenerative state of injured neurons are considered to be crucial in achieving successful 
axonal regeneration (He and Jin, 2016). It has been observed that an injury to the peripheral 
axons of the primary sensory neurons can increase their intrinsic growth capacity (McQuarrie 
and Grafstein, 1973) and strongly enhances the regeneration of their central branches in the 
spinal cord (Richardson and Issa, 1984; Richardson and Verge, 1987; Neumann and Woolf, 
1999), a phenomenon termed conditioning lesion. Although the exact mechanism of 
conditioning lesion is still under debate, strong evidence indicates that neuropoietic 
cytokines, especially, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), 
and interleukin-6 (IL-6), play an important role (Snider et al., 2002; Raivich and Makwana, 
2007; Richardson et al., 2009). Released cytokines induce phosphorylation of signal 
transducer and activator of transcription 3 (STAT3) (Lee et al., 2004; Qiu et al., 2005; Wu et 
al., 2009), which switches on the transcription of growth related molecules in injured 
neurons. cJun and activating transcription factor 3 (ATF3) are activated in dorsal root 
ganglion (DRG) neurons as well (Herdegen et al., 1992; Tsujino et al., 2000). cAMP 
signaling pathway is also implicated in the mechanism of conditioning lesion (Qiu et al., 
2002). It is evident that the increased growth status of neurons after peripheral nerve injury is 
mediated coordinately by multiple signaling pathways.  
How nerve injury triggers the molecular events that elevate the regenerative state of 
sensory neurons remains unclear (Richardson et al., 2009). Better understanding of the 
molecular events underlying this phenomenon could lead to practical methods to boost the 
intrinsic regenerative capacity. Extracellular ATP has a broad range of biological activities 
including glia-glia and glia-neuron communication (Burnstock, 2007; Abbracchio et al., 
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2009). ATP is released extracellularly by nerve or other tissue injury (Fields and Burnstock, 
2006) and acts as an injury signal in various tissues (Rodrigues et al., 2015). We postulate 
that ATP released by nerve injury triggers a series of molecular events in Schwann cells 
and/or axons, leading to the activation of regenerative machinery in the injured neurons. If 
that were the case, injection of ATP into a peripheral nerve should be able to mimic the effect 
of nerve injury in promoting the regeneration of the central branches of sensory neurons. In 
this study, we tested our theory using both in vitro and in vivo axonal growth models and 
examined the activation of several growth-related transcription factors and molecules in DRG 
neurons after ATP injection.  
 
Materials and methods 
Animals and surgical procedures. Animal experiments were conducted in accordance with 
the UK Animals (Scientific Procedures) Act 1986 under project license from the Home 
Office or approved by the regional governmental agency of the State of Saxony, Germany. 
Female Wister rats (200-250 g, 6 - 8 rats per group) were anesthetized with isoflurane. The 
spinal cord was exposed via dorsal laminectomy of the 8th thoracic vertebra and the dura was 
opened. Subsequently, bilateral dorsal column funiculus was transected with a pair of 
microscissors to a depth of 1.5 mm from the dorsal surface, and a 29 gauge needle was used 
to plough the lesion site to assure the complete transection of the dorsal column. The dura, 
muscle, and skin were then sutured. Immediately after dorsal column transection the left 
sciatic nerve at mid-thigh level was exposed and 6 µl of 150 μM ATP was injected into the 
nerve using a 31 gauge Hamilton steel needle. The needle was left in place for 1 min and then 
gradually withdrawn to prevent leakage from the needle track. Three control groups were 
used: (1) injection of 6 µl of 0.9% NaCl (saline) into sciatic nerve; (2) crush of left sciatic 
nerve with a jeweler’s forceps for 15 sec at mid-thigh level; (3) sham-operation with the 
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exposure of sciatic nerve only. The experimental procedures for double sciatic nerve 
treatments are described in the Results. Animals were allowed to survive for 6 weeks after 
surgery. Three days before perfusion of the animals, 5 µl of 1% cholera toxin B subunit 
(CTB, List Biological Laboratories) was injected into the left sciatic nerve at hip level to 
trace the axons. 
In order to identify the purinoceptor subtypes involved in promoting axonal growth after 
conditioning lesion and ATP injection, we also carried out sciatic nerve injection and crush in 
P2X7 receptor knockout (P2X7R_KO) and P2Y2 receptor knockout (P2Y2R_KO) mice. 
Homozygous P2X7R_KO (P2X7R-/-) mice line was a generous gift from GSK plc, which was 
bred to a C57BL/6 background (Chessell et al., 2005). We confirmed the P2X7R deficiency 
by genotyping and immunostaining of thymus, lungs, and sciatic nerves with anti-P2X7R 
antibody (Luo et al., 2013). P2Y2R_KO mice were originally generated on a B6D2 
background (a hybrid between female C57BL/6 and male DBA/2 mice) and further cross-
bred with 129Sv mice in Prof. Beverley Koller’s laboratory (University of North Carolina) 
(Homolya et al., 1999). At the Rudolf Boehm Institute of Pharmacology and Toxicology, 
Leipzig, the P2Y2R_KO colony was backcrossed to 129S2/SvHsd for a total of nine 
generations and mating of heterozygous animals provided P2Y2R_KO and wild-type 
littermates. We confirmed the P2Y2R deficiency by genotyping. The surgical procedures 
were carried out in this institute. The sciatic nerve crush and injection procedures on mice 
were similar to those for rats. Female mice (20 – 25 g) were anesthetized with isoflurane, 2 µl 
of saline, ATP, or UTP was injected into the left sciatic nerve at mid-thigh level using a 31 
gauge Hamilton steel needle.  
    Neurite outgrowth assay. Four groups of rats (n = 4 per group) were subjected to sham 
operation, sciatic nerve crush, injection of 6 µl of 150 μM ATP or 6 µl of saline. Three days 
after the surgery, rats were killed and ipsilateral L4 and L5 DRG were removed and digested 
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with 0.125% collagenase (type XI, Sigma-Aldrich) and triturated in 1 ml BSF2 medium (F-
12/DMEM, N2 supplement [Thermo Fisher], 0.3% bovine serum albumin [BSA], and 
penicillin/streptomycin) and centrifuged through a cushion of 2 ml 15% BSA at 100 ×g for 5 
min. The cell pellet was re-suspended in BSF2 and the dissociated neurons were plated at 
1,000 cells per well in 8-well chamber slides precoated with poly-L-lysine and laminin (0.1 
μg per well, Thermo Fisher). Neurons were fixed 16 h after seeding and immunostained with 
a mouse monoclonal β tubulin III antibody (see Table 1 for antibody information). The length 
of the longest neurite of each neuron was measured using ImageJ (https://imagej.nih.gov/ij/). 
The percentages of neurons with neurites longer than the diameter of their somata were also 
counted. Two wells of DRG neuron cultures per animal and 200 - 400 neurons per well were 
quantified.  
Immunohistochemistry. Detailed information on the antibodies used in this study is listed 
in Table 1. For quantification of regenerating axons after dorsal column transection, animals 
were perfused 6 weeks after injury. A 10 mm lesion block centered at the lesion site was 
removed and sagittal longitudinal sections of 12 μm thick were cut and mounted on a series 
of slides (see Fig. 2A for the orientation of the sections). For identification of CTB-labeled 
axons in dorsal column and lesion epicenter, sections were immunostained with goat anti-
CTB antibody and mouse anti-glial fibrillary acidic protein (GFAP), followed by incubation 
with biotinylated donkey anti-goat IgG and FITC-conjugated donkey anti-mouse IgG. 
Sections were then incubated in Streptavidin Alexa Fluor 568. Photomicrographs were taken 
using a digital camera attached to a Leica DM5000 epifluorescence microscope. Confocal 
microscopy images of CTB-labeled axons in the spinal cord lesion epicenter were captured 
by a Zeiss LSM 710 confocal microscope using a 63 oil objective. Images were taken at a z-
stack of 34 sections with section interval of 0.348 µm. Each series of z-stack images was 
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processed with a maximum intensity projection tool to create a final image with pixels 
containing the maximum value at the whole stack. 
  CTB-labeled axons in the white matters were counted in 6 – 7 sagittal sections at 36 μm 
intervals encompassing all CTB-labeled dorsal column axons. For the experiment with single 
ATP or saline injections, as no axons grew across the lesion epicenter, we counted the 
numbers of CTB-labeled axons at 3 distance points: 0.35 mm, 1.05 mm, 1.75 mm caudal to 
the caudal border of the lesion epicenter, and those axons growing into the lesion epicenter in 
a sagittal longitudinal section. For double injection experiment, the lesion epicenter was 
divided into three equal regions: caudal, central, and rostral. CTB-labeled axons growing 
across the lesion epicenter into the rostral region with reactive astrocyte processes 
immediately adjacent to the lesion epicenter were counted in 3 distance points: 0.35 mm, 
1.05mm and 1.75 mm rostral to the arbitrary boundary defined by GFAP immunoreactivity. 
  For detecting the expression of the activated transcription factors (pSTAT3, pcJun, and 
ATF3) and GAP43 in rat and mouse L4-5 DRG, DRG sections were incubated with rabbit 
anti-phospho-STAT3 (Tyr705), rabbit anti-phospho-cJun, rabbit anti-ATF3, or rabbit anti-
GAP43, followed by incubation with goat anti-rabbit IgG Alexa Fluor 568 conjugate. The 
nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI). The proportion of DRG 
neurons with activated transcription factors or GAP43 was determined by analyzing 300 – 
500 neurons with visible nuclear profiles (by DAPI staining) per DRG in randomly chosen 
sections. 
      To exam the morphological change of sciatic nerves after nerve crushes or injections of 
ATP, animals were perfused 3 days after the treatments. Longitudinal sections (8 µm thick) 
were double-stained with mouse anti-myelin protein P0 antibody plus rabbit anti-
neurofilament 200 (NF200) antibody, or mouse anti-S100 antibody plus rabbit anti-p75NTR 
antibody overnight at room temperature, followed by incubation with Alexa Fluor 568 
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conjugated goat anti-mouse IgG antibody and goat anti-rabbit IgG Alexa Fluor 488 conjugate 
antibody for 2 h. Images were taken at three regions from the sciatic nerve: at the center of 
the crush or injection site (the central region), 1.4 mm proximal and 1.4 mm distal to the 
crush or injection site. From each animal, four images from each region were taken for 
quantification. Integrated densities of P0, NF200, S100, and p75NTR immunoreactivity were 
measured with ImageJ. 
     ELISA. To investigate whether ATP injection can induce the expression of IL-6, we 
measured the levels of IL-6 in DRG and sciatic nerves. Three days after single sciatic nerve 
treatments (3 rats per group), left L4-5 DRG and a 1-cm segment of left sciatic nerve 
encompassing the injection or crush site were removed. Segments of sciatic nerves 
corresponding to the same positions as those of treated sciatic nerves were also removed from 
the sham-operated animals. Soluble proteins were extracted from the tissues and protein 
concentrations were measured using a DC Protein Assay kit (Bio-Rad). Concentrations of IL-
6 were measured using a Quantikine® ELISA kit (R&D Systems) according to the instruction 
of the kit.  
Tests for sciatic nerve function. To investigate whether double intraneural injection of 
ATP has any adverse effect on sciatic never functions we carried out behavioral tests on 
sensory function and motor functions. Female Wistar rats (200 g) were divided into 4 groups 
(5 per group): sham operated control, intraneural injection of saline/saline, ATP/saline, and 
ATP/ATP. The animals were accommodated to the behavioral equipment for 10 min every 
day for a week prior to the tests. Tests for baseline were carried out 3 days prior to the first 
intraneural injection. Behavioral tests were carried out on day 2 and 6 after the first injection. 
The second intraneural injection was performed on day 7, and behavioral tests were 
continued on day 9, 13, 16, and 20. The experimenter was blind to treatment groups 
throughout the testing period. 
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Mechanical sensitivity was assessed by measuring paw withdrawal threshold using Von 
Frey hairs according to the ‘up-down’ method as previously described (Dixon, 1980; Chaplan 
et al., 1994). Noxious thermal sensitivity was assessed using the Hargreaves’ method 
(Hargreaves et al., 1988), by measuring the time taken for a radiant heat source to elicit a 
flexion reflex. For footprint analysis, rat hindpaws were covered with ink to record walking 
patterns during continuous locomotion across a wooden runway (8 120 cm). The hindpaw 
1st - 5th toe spread was measured and used as an indicator of functional recovery of injured 
sciatic nerve (Walker et al., 1994). In the grid walking test rats were trained to cross a wire 
grid (40  65 cm with 5  5 cm grid squares). Hindlimb slips were recorded (determined by a 
paw slipping below the plane of the grid) among the first 30 steps.  
    Experimental design and statistical analysis. The details for quantification of neurites, 
transcription factors and GAP43, and CTB-labeled axons in the spinal cord are described in 
the relevant sections above. Statistical analyses for neurite outgrowth, rat DRG neurons 
expressing activated transcription factors or GAP43, IL-6 levels, CTB-labeled axons among 
different groups, and the quantification data of sciatic nerve markers were conducted using 
one-way ANOVA with post hoc Tukey tests in SPSS software. Two-way ANOVA with post 
hoc Tukey tests were used for analyzing the behavioral data to compare the changes before 
and after the treatments of the same groups and among different groups, for analyzing the 
DRG neurons expressing activated transcription factors or GAP43 in P2X7R_KO or 
P2Y2R_KO mice and the wild-type mice of the same genetic background. All data are shown 
as means ± SEM. 
 
Results 
Single intraneural ATP injection enhances neurite outgrowth of DRG neurons 
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To prove our hypothesis that sciatic nerve injection of ATP can mimic the effect of 
conditioning lesion, we first investigated whether injection of ATP into rat sciatic nerves 
could promote the neurite outgrowth of DRG neurons dissociated and maintained in vitro. 
Four groups of adult rats were subjected to sham-operation, sciatic nerve crush, normal saline 
injection, or ATP (150 M) injection and the DRG neurons were isolated from the animals 3 
days later. After 16 h in culture, DRG neurons grew neurites to different lengths (Fig. 1A) 
and 23  2% of DRG neurons in sham-operated group grew neurites longer than the 
diameters of their cell bodies (Fig. 1B). Sciatic nerve crush significantly increased the 
percentage of neurite-bearing cells to 68  2% (p = 2.7 × 10-8 compared with sham group, n = 
5). In the saline injection group the proportion of the neurite-bearing neurons was 31  3%, 
which is not significantly different from the sham-operated group. Injection of ATP increased 
the neurite-bearing cells to 57  2%, which is significantly higher than the saline injected 
group (p = 5.1 × 10-5, n = 5). A similar pattern of results was obtained by measuring the 
longest neurite of each neuron (Fig. 1C). Neurons from sciatic nerve crush group had much 
longer neurites than those from sham-operated group (147  8 vs. 27  4 m, p = 2.1 × 10-9, 
n = 5). In the saline injected group, the neurite length was 47  7 m, which was not 
significantly longer than that of the sham operated group, but significantly shorter than the 
ATP injection group (111  4 m) (p = 1.5 × 10-5, n = 5). The results show that a single 
intraneural ATP injection elevates the regeneration capacity of DRG neurons and promotes 
neurite outgrowth. 
 
Single intraneural ATP injection enhances sensory axonal regeneration in spinal cord 
To investigate whether the axon-growth promoting effect of intraneural ATP injection can be 
achieved in vivo, the dorsal column of the spinal cord was transected bilaterally at T8 in adult 
rats, which were subjected to one of the four treatments to the sciatic nerves described above. 
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Transganglionic tracer CTB was used to label the ascending sensory axons. Six weeks after 
surgery, animals were sacrificed and spinal cord segments containing the lesion site were 
sectioned and stained with an anti-CTB antibody. CTB-labeled axons were clearly visible in 
sagittal spinal sections containing the lesion sites in all four groups (Fig. 2B). End-bulb 
structures could be seen at various distances caudal to the lesion epicenter, which were most 
abundant in the area within 2 mm of the caudal border of the lesion epicenter. For statistical 
analysis three points caudal to the border of lesion epicenter (defined by GFAP 
immunoreactivity) were arbitrarily selected and the CTB-labeled axons at each distance point 
and those inside the lesion epicenter were counted (Fig. 2A, F). At 1.75 mm and 1.05 mm 
caudal to the border of the lesion epicenter, the numbers of CTB-labeled axons did not differ 
significantly among the four groups (Fig. 2F). However, more CTB-labeled axons were 
found at 0.35 mm caudal to the epicenter border or within the lesion epicenter in the nerve 
crush and the ATP injected groups than the sham-operated and saline injected groups (Fig. 
2C). At 0.35 mm to the caudal border of lesion epicenter, 35  3 CTB-labeled axons per 
animal were counted in the sham-operated group, while 144  21 were seen in the sciatic 
nerve crush group. In the saline injection group, 42  8 CTB-labeled axons were counted, 
which is similar to the sham-operated group, but significantly lower than the ATP injection 
group (130  25, p = 0.027, n = 6, Fig. 2C). No significant difference in CTB-labeled axon 
numbers was seen between the sciatic nerve crush and the ATP injection group. Inside the 
lesion epicenter few CTB-labeled axons were found in the sham-operated (19 ± 4) and saline 
injection groups (23 ± 5), while significantly more CTB-labeled axons were counted in the 
lesion epicenter in the sciatic nerve crush group (131 ± 23, p = 1.5 × 10-5 compared with the 
sham-operated group, n = 6). Also the number of CTB-labeled axons in the lesion epicenter 
in the ATP injection group (96 ± 16) was significantly higher than the saline injection group 
(p = 0.0014, n = 6), but lower than the nerve crush group (p = 0.049, n = 6). The data from 
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this in vivo study demonstrate that ATP injection into a peripheral nerve is able to promote 
the regeneration of the corresponding central sensory axons.  
 
Double intraneural ATP injection markedly enforces the stimulatory effect of a single 
ATP injection  
In view of a report that a second peripheral nerve transection significantly increases the 
enhancement of central sensory axonal regeneration compared to a single nerve transection 
(Neumann et al., 2005), we assessed the effects of a second ATP injection one week after the 
first one. Three groups of animals were subjected to dorsal column transection: one group 
underwent two intraneural ATP injections one week apart (ATP/ATP group); the second 
group underwent ATP injection, followed by saline injection one week later (ATP/saline 
group); the third group underwent two saline injections (saline/saline group). All the other 
experimental procedures were the same as those of single treatment experiments. CTB-
labeled axons were counted in the spinal cord at various distances caudal or rostral to the 
lesion epicenter as well as at three regions inside the lesion epicenter: caudal, central, and 
rostral (Fig. 4). As it is shown in the montaged fluorescence images and their corresponding 
camera lucida drawings (Fig. 3A-C), in the saline/saline group a small number of CTB-
labeled axons grew into the caudal region of lesion epicenter (22  4) (Fig. 4), and only a few 
axons grew into the central region of lesion epicenter, but no axon grew to the rostral region 
of the lesion epicenter (Fig. 3A). In the ATP/saline group, more axons entered the lesion 
epicenter than in the saline/saline group (Fig. 4), and a few CTB-labeled axons extended to 
the rostral region of lesion epicenter (Fig. 3B).  The counts of CTB-labeled axons were 146  
25, 43  10, and 7  3 in the caudal, central, and the rostral regions inside the lesion, 
respectively. In the ATP/ATP group, a large number of CTB-labeled axons grew across the 
lesion epicenter and some of them entered the rostral spinal cord containing hypertrophic 
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astrocyte processes immediately adjacent to the lesion epicenter (Fig. 3C). In the central 
region of the lesion epicenter, the CTB-labeled regenerating axons looked disorderly and had 
many branches (Fig. 3Ca), however, when they approached the rostral border they were more 
aligned (Fig. 3Cb). The morphology of the CTB-labeled axons inside lesion epicenter is more 
clearly shown in the z-stack confocal microscopy images (Fig. 3Cc-e). The CTB-labeled 
axon counts in the caudal, central, and rostral regions in the lesion epicenter were 498  88, 
415  88, and 198  60, respectively (Fig. 4). The number of axons growing into the lesion 
epicenter in the ATP/ATP group was around 10-fold more than that in ATP/saline group, and 
166-fold more than that in the saline/saline group. A few regenerating axons extended as far 
as 1.75 mm into the rostral spinal cord from the arbitrary border defined by reactive 
astrocytes in the ATP/ATP group, while no axon in the other two groups entered the area. 
These data show that a second ATP injection markedly reinforces the stimulatory effect of 
the first ATP injection on axonal regeneration.  
 
Single intraneural ATP injection increases the expression of interleukin-6 in DRG and 
sciatic nerves 
IL-6 is considered as a major mediator in the growth promoting effects of conditioning 
lesion. Our ELISA results showed that both sciatic nerve and DRG had base level expression 
of IL-6 and the level of IL-6 in DRG was higher than sciatic nerves (Fig. 5). Nerve crush or a 
single injection of 6 µl 150 µM ATP significantly increased the IL-6 concentrations in DRG 
and sciatic nerves 3 days after treatments, while saline injection did not (Fig. 5). Thus, the 
results show that a single ATP injection into sciatic nerve has a similar effect to nerve crush 
in inducing IL-6 expression.  
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Single intraneural ATP injection induces the activation of transcription factors and 
expression of GAP43  
Since a conditioning lesion induces the expression or activation of several transcription 
factors associated with the regenerative status of the primary sensory neurons, we also 
explored ATP-induced changes of these molecular markers. We first examined whether ATP 
injection into a peripheral nerve could activate the STAT3 signaling pathway. Three days 
after the four single treatments described above, L4-5 DRG were removed and 
immunostained for pSTAT3. In DRG from sham-operated animals, only 4 ± 1% neurons 
were positive for pSTAT3, while sciatic nerve crush increased pSTAT3+ neurons to 36 ± 4% 
(Fig. 6A, B). Saline injection also caused moderate increase in pSTAT3+ neurons (10 ± 1%), 
but not significantly higher than the sham-operated group. Injection of ATP led to an increase 
of pSTAT3+ neurons to 21 ± 2%, which was significantly higher than the saline injection 
group (p = 0.01, n = 4), but significantly lower than the sciatic nerve crush group (p = 0.003, 
n = 4). The results demonstrate that intraneural injection of ATP can activate the STAT3 
signaling pathway, although not as potent as nerve crush. 
The other two transcription factors examined were pcJun (Fig. 6C, D) and ATF3 (Fig. 6E, 
F). In sham-operated animals, the numbers of both ATF3+ and pcJun+ neurons in DRG were 
rather low (1.5 ± 0.4% and 2 ± 1%, respectively), indicating that the procedure of exposing 
the nerve did not induce injury responses in the neuronal cell bodies. Nerve crush increased 
the ATF3+ neurons to 60 ± 2% and pcJun to 45 ± 3%. Single saline or ATP injection 
moderately increased the percentages of ATF3+ (15 ± 2% and 15 ± 5%, respectively) and 
pcJun+ (15 ± 2% and 11 ± 2%, respectively) neurons; however, there was no significant 
difference between saline and ATP injection groups, indicating that the increased expression 
of ATF3 and pcJun was caused by the injection procedure. 
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    GAP43 is also considered as a marker for neurons’ propensity for axonal regeneration 
(Schreyer and Skene, 1991; Hu-Tsai et al., 1994; Liu et al., 2011). Various levels of GAP43 
immunoreactivity were observed in the cytoplasm of 19 ± 2% DRG neurons in sham-
operated animals (Fig. 6G, H). Sciatic nerve crush significantly increased the number of 
GAP43+ DRG neurons (49 ± 3%). In the saline injection group 22 ± 1% neurons were 
GAP43+, which was not significantly higher than the sham-operated animals. ATP injection 
increased the percentage of GAP43+ neurons to 35 ± 2%, which is significantly higher than 
the saline injected animals (p = 0.004, n = 4), but lower than the nerve crush group (p = 
0.005, n = 4). Thus, single ATP sciatic nerve injection can increase the expression of GAP43 
in DRG neurons, although to a lower extent compared with nerve crush.  
 
Double intraneural ATP injection sustains the activation of transcription factors and 
the expression of GAP43  
To investigate whether a second ATP injection can boost and sustain the expression of 
pSTAT3 and GAP43 in DRG neurons, four groups of rats were subjected to double sham 
operations (sham/sham), saline/saline, ATP/saline, and ATP/ATP double injections one week 
apart. Animals were maintained for 20 days after the initial injection before they were 
sacrificed. Percentages of pSTAT3+ neurons in DRG were 12 ± 1%, 20 ± 3%, 30 ± 1%, and 
45 ± 3% in sham/sham, saline/saline, ATP/saline, and ATP/ATP groups, respectively (Fig. 
7A, B). There was no significant difference between sham/sham and saline/saline groups. 
ATP/saline group has significantly more pSTAT3+ neurons than saline/saline group (p = 
0.04, n = 3); while ATP/ATP group has more pSTAT3+ neurons than both saline/saline and 
ATP/saline groups (p = 0.0001 and 0.006, respectively, n = 3). The results suggest that 
sustained activation of STAT3 by double ATP injection may contribute to the significantly 
enhanced axonal growth in the lesioned spinal cord shown above. 
 18 
      We also examined the GAP43 expression in DRG from the four groups of rats with 
double treatments. The percentages of GAP43+ DRG neurons were 23 ± 2%, 27 ± 1%, 42 ± 
1%, and 60 ± 4% in sham-operated, saline/saline injected, ATP/saline injected, and ATP/ATP 
injected groups, respectively (Fig. 7C, D). The ATP/saline group had significantly more 
GAP43+ neurons than saline/saline group (p = 0.008, n = 3); however, the percentage of 
GAP43+ neurons in ATP/ATP group was significantly higher than both saline/saline (p = 1.3 
 10-5, n = 3) and ATP/saline group (p = 0.003, n = 3), suggesting that more DRG neurons 
entered and maintained in regenerative state after the second ATP injection. 
 
Knocking out P2X7 receptor has no effects on the expression of axon growth associated 
proteins  
P2X7R_KO mice were subjected to sham surgery, nerve crush, saline and ATP injection. L4-
5 DRG were taken 3 days after treatments. Immunohistochemistry results show that sciatic 
nerve crush significantly increased the expression of pSTAT3, pcJun, ATF3, and GAP43 in 
DRG neurons of both C57BL/6 wild-type and P2X7R_KO mice (Fig. 8). However, there is 
no significant difference between the wild-type and P2X7R_KO mice in all four molecular 
markers. Saline injection significantly increased the percentages of pSTAT3+ and pcJun+ 
neurons compared with the sham-operated group, while with injection of 1 mM ATP (a 
higher dose was used to activate P2X7R) significantly more neurons were pSTAT3+, ATF3+, 
and GAP43+ than those in saline injected group.  No difference was detected between the 
groups of wild-type and P2X7R_KO mice in both saline and ATP injected groups. Also after 
T8 dorsal column transection, profile of regenerating axons of P2X7R_KO mice did not show 
significant difference with that of wild-type mice (data not shown). These results implicate 
that P2X7R may not be involved in sensory axon regeneration after conditioning lesion or 
intraneural ATP injection.   
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Knocking out P2Y2 receptor reduces the number of pSTAT3+ DRG neurons.  
To investigate the involvement of P2Y2R in conditioning lesion, apart from sciatic nerve 
crush and ATP injection, we also carried out sciatic nerve injection of UTP, a relatively 
selective agonist for P2Y2R (Burnstock, 2012). Three days post injection ATP (150 µM) or 
UTP (300 µM) significantly increased the percentage of pSTAT3+ DRG neurons of the wild-
type mice compared with the saline injected group (p = 0.006 and 0.05 respectively, n = 4) 
(Fig. 9A). The percentages of pSTAT3+ neurons in P2Y2R_KO mice in crush, ATP and UTP 
injection groups were significantly lower than the relevant wild-type groups (p = 0.0002, 
0.001, and 0.045, respectively, n = 4), while there is no statistical significance between the 
P2Y2R_KO and the wild-type in the saline-injected group. These results indicate that P2Y2R 
plays a role in mediating STAT3 activation after conditioning lesion and ATP injection.    
       No significant difference  in the percentages of pcJun+ neurons was detected between the 
P2Y2R_KO and the wild-type mice in all the four treatment groups although ATP injection 
increased the percentage of pcJun+ neurons more than UTP injection in the wild-type mice 
(Fig. 9B). Similarly, ATP injection increased the percentage of ATF3+ neurons than UTP 
injection in the wild-type mice (Fig. 9C). Significant difference was seen between the 
P2Y2R_KO and wild-type mice in ATP injection group, but not in UTP and crush groups. 
Both ATP and UTP injections also significantly increased the expression of GAP43 in DRG 
neurons in the wild-type mice compared with saline-injected mice (p = 2.1 × 10-6 and 0.004, 
respectively, n = 4) (Fig. 9D). Again, ATP injection induced GAP43 expression in more 
neurons in the wild-type mice than in the P2Y2R_KO mice while UTP injection did not.  
 
Intraneural ATP injection does not cause significant damage to the injected nerves 
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As intraneural injection is an invasive procedure, we examined the morphological changes at 
the injection sites of sciatic nerves. We immunostained for Schwann cell marker S100, 
peripheral myelin protein P0, neurofilament 200 (NF), and p75 neurotrophin receptor 
(p75NTR, a marker for de-differentiated Schwann cells during Wallerian degeneration) in 
sections of nerves removed 3 days after sham operation, nerve crush, single saline and single 
ATP injections. As expected, nerve crush caused significant reduction of P0, S100, and NF 
immunoreactivity at the crush center (Fig. 10). NF and P0 immunoreactivity in sciatic nerve 
distal to the crush site also reduced significantly, indicating the occurrence of Wallerian 
degeneration. S100 immunoreactivity in the distal sciatic nerve was not reduced, indicating 
that no significant Schwann cell death occurred. Nerve crush markedly increased p75NTR 
immunoreactivity in the proximal, central, and distal regions of the nerve. Single injection of 
saline and ATP did not cause obvious changes in P0, S100, and NF immunoreactivity in the 
proximal, central and distal injection site, but did increase p75NTR immunoreactivity. These 
observations indicate mild injury to axons in the injected nerves.  
 
Double injections do not cause long-term abnormality in sensory and motor functions 
To exclude the possibility that intraneural ATP injection may affect sciatic nerve functions, 
we carried out behavioral tests for the motor and sensory functions of the hindlimbs. Four 
groups of rats were subjected to tests for grid walking, hindpaw withdrawal upon mechanical 
or thermal stimulation, and footprint analysis after double sham operation or saline/saline, 
ATP/saline, and ATP/ATP double injections one week apart. Single and double injections of 
either saline or ATP did not cause significant change in mechanical thresholds of hindpaws 
during the 20 days testing period (Fig. 11A). Rats showed mild thermal hyperalgesia 2 days 
after the first ATP injection (Fig. 11B). The thermal withdrawal thresholds returned to 
baseline level 6 days later and did not significantly change after the second injection. 
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Similarly, at day 2 after the first injection of either saline or ATP, the spread between the 1st 
and 5th toe was reduced (Fig. 11C), but returned to baseline level at day 6 and remained at 
the baseline level throughout the testing period. For grid walking test, rats from the injection 
groups made more footslips than normal on day 2, but recovered by day 6 (Fig. 11D). The 
results show that injection of ATP or saline caused mild injury to the sciatic nerve soon after 
injection; but that both sensory and motor functions recovered in a few days.  
 
Discussion  
We have found that injection of ATP into a peripheral nerve can enhance regeneration of the 
corresponding central axons in the spinal cord and that two injections one week apart are far 
more effective than one, which supports our hypothesis that intraneural ATP injection can 
mimic the stimulatory effect of a conditioning lesion. ATP injection is also able to activate 
transcription factor STAT3 and increase the expression of GAP43 in DRG neurons in the 
same way as nerve injury does, further implicating that the release of endogenous ATP from 
injured cells may act as an injury signal, triggering the regenerative response of injured 
neurons. ATP has been implicated as an injury signal in brain and peripheral nerve injury. 
Local brain and spinal cord injury causes ATP release from damaged tissues (Wang et al., 
2004; Franke et al., 2006) and the surrounding astrocytes, inducing rapid response of 
microglia towards injury (Davalos et al., 2005). Compression of peripheral nerve trunks 
resulted in immediate release of ATP (Grafe et al., 2006) and the released ATP is implicated 
to play a role in peripheral nerve degeneration and regeneration (Jung et al., 2014).  
The links between the increased concentration of extracellular ATP in sciatic nerve after 
injection of ATP and the enhanced regenerative state of DRG neurons are still not fully 
understood. Since ATP injection activates STAT3 in DRG neurons, inducing the expression 
and release of neuropoietic cytokines may be a crucial step for the stimulatory effect on 
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axonal growth. IL-6 is implicated in mediating the enhanced regenerative activity of DRG 
neurons after a peripheral nerve injury (Zhong et al., 1999; Cafferty et al., 2004). In this study 
we showed that a single ATP injection into sciatic nerve had a similar effect to nerve crush in 
increasing IL-6 expression in DRG and sciatic nerves (Bolin et al., 1995; Murphy et al., 
1995). We also measured the concentrations of LIF and CNTF in sciatic nerves and DRG, 
however, the results were not informative due to the levels of LIF and CNTF were at the 
lower end of the detectable range. 
Since ATP can be degraded rapidly in injected nerves, identification of the purinoceptor 
subtypes that are responsible for ATP induced axonal growth may suggest the use of more 
potent and degradation-resistant agonists than ATP. Extracellular ATP can activate most of 
the seven P2X (ATP-gated cation channels) and eight P2Y (G-protein coupled) purinoceptor 
subtypes. Furthermore, ATP is degraded to ADP, AMP, and adenosine and these purines can 
also activate purinoceptors such as P2Y1, P2Y12 and adenosine receptors (Burnstock, 2007). 
ATP is reported to induce transient increase of intracellular calcium in Schwann cells, a 
process mediated by P2Y receptors (Lyons et al., 1994) as well as P2X7 receptors (Luo et al., 
2013). Since it is known that activation of P2X7R can lead to release of cytokines such as IL-
1 (Ferrari et al., 2006), we postulated that it might also be involved in the release of IL-6 
and LIF, leading to the activation of STAT3. However, no difference in the activation of the 
three transcription factors and upregulated expression of GAP43 was observed in sciatic 
nerve crush, ATP and saline injected P2X7R_KO and the wild-type mice, which may exclude 
the involvement of P2X7R in the increased regenerative state of DRG neurons induced by 
conditioning lesion or ATP injection. UTP, an agonist for P2Y2 receptor subtype, was 
reported to release ATP from cultured Schwann cells (Liu et al., 2005). Injection of ATPS, a 
non-selective agonist for several P2Y receptor subtypes, into sciatic nerve increased GAP43 
expression in sciatic nerves of wild-type mice, but not in P2Y2R_KO mice (Arthur et al., 
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2005), indicating this receptor subtype may participate in ATP elevated regenerative state of 
DRG neurons. In this study, sciatic nerve crush, ATP and UTP injection significantly 
activated STAT3 in DRG neurons in the wild-type mice, while the percentages of pSTAT3+ 
DRG neurons of P2Y2R_KO mice after the three treatments were significantly lower and not 
different from the saline-injected wild-type and P2Y2R_KO mice. These results indicate that 
P2Y2R is the P2 receptor subtype that is responsible for activation of STAT3. Using qPCR 
we have found that rat DRG, sciatic nerve, and cultured Schwann cells had high-level P2Y2R 
mRNA (unpublished data). P2Y2R proteins were expressed in DRG neurons, as detected by 
Western blot (Arthur et al., 2005). P2Y2R mRNA transcripts (Molliver et al., 2002) and 
proteins (Mo et al., 2013) were located in rat DRG neurons. We anticipated that P2Y2R was 
expressed by myelinating Schwann cells as well. However, we found that the anti-P2Y2R 
antibody we used (Alomone Labs) was not so specific since immunoreactivity was seen in 
DRG and sciatic nerves of P2Y2R-KO mice as well. Further studies on the cellular location 
of P2Y2R in sciatic nerves may shed light on the mechanisms of P2Y2R mediated axon 
growth. We have also identified the mRNAs of all other purinoceptor subtypes apart from 
P2Y11R in rat sciatic nerves, cultured Schwann cells, and DRG (unpublished data). It is 
likely that some other purinoceptor subtypes may also participate in the stimulatory action of 
ATP on axonal growth.  
      The data from this study also suggest that intraneural ATP injection could be developed 
into a clinically applicable treatment for overcoming one of the major obstacles to axonal 
regeneration in the adult mammalian CNS, namely poor intrinsic regenerative capacity. 
Although a conditioning lesion has been used frequently in animal models to promote 
sensory axonal regeneration as part of combinatory strategies (Zhang et al., 2007a; Zhang et 
al., 2007b; Kadoya et al., 2009; Blesch et al., 2012), it is not feasible to apply it clinically. In 
this study, we observed only mild histological changes in the injected nerves 3 days after 
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injection and the adverse effects on the sensory and motor functions of the injected nerve 
subsided in a few days in the double injection experiments. We also examined the 
distribution of calcitonin gene related peptide (CGRP), substance P and isolectin B4 (IB4) 
positive fibers in the dorsal horn of lumbar spinal cord 20 days after double injections and did 
not observe significant sprouting of these nociceptive fibers (unpublished data). These 
findings support the observations from our behavioral tests that intraneural ATP injection 
does not induce hyperalgesia. On the other hand, a higher density of GAP43 positive fibers 
was observed in laminae III - V of the ipsilateral dorsal horn than the corresponding laminae 
in the contralateral dorsal horn in the ATP/saline and ATP/ATP injection groups 
(unpublished data). Laminae III - V are where the myelinated mechanoceptive axons project 
to, which corroborates the observation of enhanced regeneration of myelinated axons in the 
injured dorsal columns.  
 Our finding that a second ATP injection markedly boosted the stimulatory effect of a 
single injection mimicked what was reported by Neumann et al. (Neumann et al., 2005). 
Using a dorsal column transection model, they found that a second transection of the sciatic 
nerve a week after the first was able to promote ascending axons to grow across the lesion 
while a single sciatic nerve transection did not. Repeated priming sustained the regenerative 
state of DRG neurons. It was shown previously that the percentage of pSTAT3+ DRG 
neurons after sciatic nerve transection dropped from 90% at 6 h post injury to 36% 7 days 
post injury, indicating that the conditioning effect may weaken in a week (Qiu et al., 2005).  
It is, therefore, not surprising that a second sciatic nerve transection or a second intraneural 
ATP injection a week later can boost the regeneration state of DRG neurons markedly. It is 
expected that repeated intraneural ATP injections may continue to sustain the regenerative 
state of DRG neurons; however, the procedure may not be practical. A different approach for 
repeated intraneural administration of ATP needs to be developed.  
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Since the axon growth promoting effect after double ATP injections was markedly more 
potent than a single ATP injection, one question raised is that whether the needle injury of the 
first injection acted as a priming injury. Although we believe the effect of double ATP 
injections is mainly attributed to the biological actions of ATP, further study may be carried 
out to exclude the possibility that a concomitant axon injury is required for the axon growth 
promoting effect of ATP.  
In this study, spinal cord injury and ATP injection were performed concomitantly, which 
will not occur in a clinical practice. Therefore, the efficacy of ATP injection in promoting 
sensory axonal regeneration needs to be tested in subacute and chronic injury animal models. 
A previous study showed that chronically injured DRG neurons acquire the intrinsic potential 
via conditioning lesion to regenerate their axons months after a CNS lesion (Ylera et al., 
2009). We predict that intraneural ATP injection should also be able to elevate the 
regenerative state of DRG neurons in subacute and chronic dorsal column transection models. 
However, any successful therapeutic strategies will also have to deal with the poor cellular 
environment in the CNS for axonal regeneration and the challenge of directing axons to their 
original synaptic targets. Although we have demonstrated that double intraneural ATP 
injection can promote axon growth across the lesion epicenter, we anticipate that more 
profound axonal regeneration may be achieved if ATP injection is combined with other 
strategies such as blocking the myelin-associated inhibitors (Gonzenbach and Schwab, 2008; 
Wu et al., 2009), degrading chondroitin sulfate proteoglycans (Bradbury et al., 2002), over-
expressing growth permissive molecules like polysialic acid (Zhang et al., 2007b), and 
providing cellular bridging using transplanted cells (Kadoya et al., 2009). 
 In conclusion, this study demonstrates that intraneural injection of ATP can elevate the 
regenerative state of DRG neurons and stimulate the growth of their central axons in injured 
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spinal cord, while has no significant adverse effects on injected nerves, suggesting such an 
approach in stimulating sensory nerve regeneration is clinically translatable.  
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Figure 1. Intraneural injection of ATP enhances neurite outgrowth of DRG neurons.  A. 
Cultured DRG neurons immunstained with an anti-βIII tubulin antibody showing the neurite 
growth from four experimental groups: sham operation, sciatic nerve crush, sciatic nerve 
injection of saline or ATP. Scale bar =100 µm. B, C, Quantification of the percentages of 
neurite-bearing neurons (B) and neurite lengths (C) in the four groups. ***p < 0.001, n = 4, 
one-way ANOVA with post hoc Tukey test.   
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Figure 2. Intraneural injection of ATP promotes axonal regeneration after dorsal column 
transection.   A, Scheme showing the spinal cord segment containing the T8 dorsal column 
lesion. Light grey lines indicate the sagittal sections through the dorsal column. Green 
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irregular line indicates the glial scar surrounding the lesion cavity. Red lines represent CTB-
labeled axons. Dotted lines indicate the 3 distance points for counting the CTB-labeled axons. 
B - E, Photomicrographs showing CTB-labeled axons (red) growing towards the caudal 
lesion border (defined by GFAP immunoreactivity, green) or into the lesion in spinal cord 
sagittal sections from the 4 groups. The boxed areas in D and E are shown at higher 
magnification in Da and Ea. Scale bars = 100 µm. F, Quantification of CTB-labeled axon 
numbers in the lesion cavity and caudal to the lesion cavity. p < 0.05, **p < 0.01, ***p < 





Figure 3. Double intraneural injection of ATP promotes profound axonal regeneration after 
dorsal column transection. A - C, Montages of photomicrographs showing CTB-labeled 
sensory axons (red) growing into or across the lesion epicenter (defined by green GFAP 
immunoreactivity, and marked by dashed lines) in sagittal sections of spinal cord from 
saline/saline (A), ATP/saline (B), and ATP/ATP (C) double injection groups. Camera lucida 
drawings corresponding to the same micrographs are used to map the CTB-labeled axons 
inside and around the lesion epicenters. Scale bar = 100 µm. Boxed areas in (C) are enlarged 
in (Ca) and (Cb). Scale bar = 50 µm. Cc – Ce, z-stack confocal microscopy images showing 
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CTB-labeled axons in the rostral (100 μm from the rostral boundary line), central, and caudal 
(200 μm from the caudal boundary line) regions of the lesion.  
 
 
Figure 4. Quantification of the numbers of CTB-labeled axons. CTB-labeled axons were 
counted in three equally divided regions within the lesion epicenter and in 3 regions on both 
the rostral and caudal sides immediately adjacent to the lesion epicenter in 6 – 7 sagittal 
sections at 36 μm intervals. The distances in both the caudal and rostral spinal cord were 
measured from the arbitrary boundaries defined by GFAP-immunoreactive astrocyte 
processes.  *p < 0.05, **p < 0.01, ***p < 0.001, n = 8, one-way ANOVA with post-hoc 






Figure 5. Single intraneural injection of ATP increases the concentrations of interleukin-6 
(IL-6) in DRG and sciatic nerves. Sandwiched ELISA was used to measure the levels of IL-6 
in protein extracts from the treated segments of sciatic nerves and DRG from the rats 
subjected to sciatic nerve crush, injections of saline or 150 µM ATP. Nerves were taken 3 d 
after treatments. The segments of sciatic nerves corresponding to those segments of the 
treated nerves were taken from the sham operated rats and used as control. ** p < 0.01; *** p 




Figure 6. Single intraneural ATP injection induces activation of transcription factors and 
expression of GAP43 in DRG neurons. Four groups of rats were subjected to sham operation, 
sciatic nerve crush, injections of saline or ATP into sciatic nerves. DRG were removed 3 days 
after the treatments and processed for immunohistochemistry. A, C, E, G, Micrographs 
showing the immunoreactivity for pSTAT3 (A), pcJun (C), ATF3 (E), and GAP43 (G) in 
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DRG neurons. Scale bar = 100 μm. B, D, F, H, Quantification of neurons with nuclear 
profiles containing immunoreactivity for pSTAT3 (B), pcJun (D), ATF3 (F), and GAP43 
(H). *p < 0.05, **p < 0.01, ***p < 0.001, n = 4, one-way ANOVA with post hoc Tukey test.  
 
 
Figure 7. Double intraneural ATP injection sustains activation of STAT3 and expression of 
GAP43 in DRG neurons. Four groups of rats were subjected to sham/sham operation, 
saline/saline injection, ATP/saline injection, and ATP/ATP injection into sciatic nerves. DRG 
were removed 20 days after the first treatments for immunohistochemistry. A, C, 
Photomicrographs showing the immunoreactivity for pSTAT3 (A) and GAP43 (C) in DRG 
neurons. Scale bar = 100 μm. B, D, Quantification of neurons with nuclear profiles 
containing immunoreactivity for pSTAT3 (B) and GAP43 (D). *p < 0.05, **p < 0.01, ***p < 






Figure 8. P2X7 receptor is not responsible for ATP induced elevation of regenerative state of 
DRG neurons. P2X7R_KO mice were subjected to sham surgery, nerve crush, saline and 
ATP injection. DRG were taken 3 days after treatments for immunohistochemistry. A – D, 
Graphs showing the percentage of neurons with nuclear profiles containing immunoreactivity 
for pSTAT3 (A), pcJun (B), ATF3 (C), and GAP43 (D). *p < 0.05, **p < 0.01, ***p < 0.001, 




Figure 9. P2Y2 receptors are involved in ATP induced elevation of regenerative state of 
DRG neurons. P2Y2R_KO mice were subjected to nerve crush, saline, UTP, and ATP 
injection. DRG were taken 3 days after treatments for immunohistochemistry. A – D, Graphs 
showing the percentage of neurons with nuclear profiles containing immunoreactivity for 
pSTAT3 (A), pcJun (B), ATF3 (C), and GAP43 (D). *p < 0.05, **p < 0.01, ***p < 0.001, n = 




Figure 10. Morphological changes of sciatic nerves after nerve crush or single intraneural 
injection of saline or ATP. Sciatic nerves were removed 3 days after treatments  
A, B, Immunoreactivity of myelin protein P0 (red in A), axon marker neurofilament 200 (NF, 
green in A), Schwann cell marker S100 (red in B), and p75NTR (green in B) in the central 
treatment region in sciatic nerves from the groups subjected to sham operation, nerve crush, 
injections of saline or ATP. Scale bars = 100 µm. C – F, Quantification of the four markers in 
the proximal, central, and distal regions of the sites of treatments. *p < 0.05; **p < 0.01; 





Figure 11. Effects of double intraneural injection of ATP on the sensory and motor function 
of sciatic nerves. A, Mechanical sensitivity assessed by measuring paw withdrawal threshold 
using Von Frey hairs. B, Noxious thermal sensitivity assessed using the Hargreaves’ method. 
C, Footprint analysis for the distance between the 1st and the 5th toe spread. D, Grid walking 
test for the number of foot slips. DPO: days post operation. *p < 0.05; **p < 0.01; ***p < 
0.001, compared with the baseline for the same group, n = 5, two-way ANOVA with post-








Company Cat. Number RRID 
Phospho-STAT3 
(Tyr705) 
1:200 Cell Signaling #9131 AB_331586 
Phospho-c-Jun (Ser63) 
(54B3)  
1:200 Cell Signaling #2361 AB_490908 
ATF3 1:500 Santa Cruz 
Biotechnology 
Sc-188 AB_2258513 
GAP43 1:10,000 Atlas Antibodies HPA015600 AB_1234436 
-tubulin III 1:400 Sigma-Aldrich T8660 AB_477590 
Myelin protein P0 1:3000 ASTEXX Ltd & 
Co KEG 
  
Neurofilament 200 1:2000 Sigma-Aldrich N4142 AB_477272 
p75NTR 1:2000 Millipore ABN1655  
S100 1:2000 Sigma-Aldrich S2657 AB_261477 
Glial fibrillary acidic 
protein (GFAP) 
1:1000 Millipore MAB360 AB_2109815 
Cholera toxin subunit B 
(CTB) 
1:4,000 List Biological  703 AB_10013220 
Goat anti-rabbit 
IgG_Alexa Fluor 568 




IgG_Alexa Fluor 568 




IgG_Alexa Fluor 488 




IgG_Alexa Fluor 568 










donkey anti-mouse IgG 
1:400 Jackson 
ImmunoResearch 
Lab 
715-096-150 AB_2340795 
 
 
 
